As announced in the January 2024 issue of the Journal (1), the Journal of the National Cancer Institute (JNCI) is piloting a new early career investigator initiative to address specific needs of early career investigators during this exciting period of rapid advances in medical research and changes in scientific publishing. This initiative was motivated...

With more than eight decades as a repository of the best cancer science available to clinicians, scientists, public health practitioners, and policymakers, the Journal of the National Cancer Institute—known more widely by its acronym JNCI—is recognized for its commitment to excellence. By every metric and reputational criterion, this medical journal...